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Abstract
Giardia lamblia is a protozoan parasite and a major cause of the waterborne-illness
(known as giardiasis) worldwide. Giardiasis is endemic in developing countries and is a leading
cause of non-viral- and non-bacterial-associated intestinal disorders. Acute symptoms of
giardiasis include diarrhea, cramps, and malabsorption. The disease is often self-limiting,
although the infection can result in long-term disorders such as chronic fatigue, stunted cognitive
skills, and failure to thrive even after the parasite has been cleared.
This parasite exists in two morphologic forms—infective trophozoites and transmissible,
water-resistant cyst, which is passed by the fecal-oral route and is likely to be spread by
contaminated drinking water. Infection can occur upon ingestion of as few as 10 cysts, and an
infected individual sheds more than 109 cysts in the feces per day. Although giardiasis can
effectively be treated with nitroheterocyclic compounds, such drugs can cause unpleasant side
effects and ultimately lead to drug-resistant parasites. Therefore, it is necessary to identify novel
targets for developing new anti-giardial agents. One of these targets could be sphingolipid (SL)
pathways because the results from our laboratory indicate that SL genes and gene products play
critical roles in regulating encystation (cyst formation) of Giardia. We have shown previously
that SL metabolism in Giardia is limited to five putative enzymes, which are differentially
regulated during the formation of water-resistant cysts. We have also shown that the silencing of
the giardial glucosylceramide synthase gene (gGlcT1) using anti-gGlcT1 morpholino
oligonucleotide results in inhibition of growth and the production of viable cysts.
The goal of my dissertation is to establish the sphingolipidome of Giardia during
encystation to provide a global perspective of the SL changes that take place during this critical
stage of the parasite’s life cycle and to show how Giardia can modulate these lipids. In Specific
Aim 1, I used mass spectrometry to elucidate the sphingolipid profile of Giardia during
encystation as well as culture media sources of SLs. In Specific Aim 2, I investigated the
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parasite’s ability to generate ceramide from the hydrolysis of sphingomyelin (SM) via two
putative sphingomyelinase (SMase) enzymes identified by mining the Giardia genome project.
Briefly, I found that the levels of ceramide and glycosylceramides increased significantly
(~10 fold) during encystation followed by a decline in cysts. The level of sphingomyelin (SM),
on the other hand, increased sharply in the cyst population. Analysis indicated that SM-enriched
cysts are viable and undergo excystation in culture. It was also observed that Giardia expresses
two active acid SMase enzymes (gASMLPD3b1 and gASMLPD3b2) with distinct pH
requirements, one of which shows the characteristics of a secreted SMase. My results indicate
that a dynamic metabolic conversion among various classes of SLs occurs during giardial
encystation, and that this conversion could be critical for completing excystation and producing
infection in the human gut.
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Introduction
People, especially children, can die from diarrheal diseases. According to the World
Health Organization (WHO), diarrhea is the second leading cause of death among children under
five, killing an estimated 760,000 children every year (WHO Bulletin 2013). Diarrheal disease
is caused by bacteria, viruses, and intestinal parasites, including Giardia lamblia (hereinafter
Giardia), a causative agent of waterborne illness or “giardiasis.” Giardiasis is classified under
the “Neglected Tropical Diseases” category and is generally self-limiting, but recurrence is
common in endemic areas (Watkins and Eckmann 2014). There is no vaccine, and treatment
with common anti-parasitic agents is confounded by adverse side effects and decreasing drug
susceptibility. Furthermore, intestinal micro flora plays an important role in determining the
severity of giardial infection. For example recent evidence suggests that reduction of helminth
infection may be associated with the increase of Giardia infection (Blackwell et al. 2013).
Helminthes modulate host lipid levels in order to carry out their own cellular processes
(reviewed by Bansal et al., 2005). Similarly, Giardia uses the host’s lipids for its growth and
differentiation because it is unable to synthesize its own lipids de novo (Das et al. 2001; Yichoy
et al. 2010). Thus, it is possible that the antagonism observed between these organisms involves
competition for intestinal lipids, which they both colonize. Investigation into additional lipids
essential for growth and/or differentiation of Giardia may provide insight into alternative
strategies for combating this disease.
Giardia trophozoites colonize the intestine of mammalian hosts. This is a low-oxygen,
nutrient-rich environment, in which the organism must contend not only with the host’s immune
response but also with the high levels of digestive enzymes constitutively secreted by the
intestinal cells. The advantage, however, is that the parasite is able to scavenge these nutrients
and thus accumulate metabolic energy that is required to synthesize organelles and
macromolecules. A basal eukaryote Giardia lack both mitochondria and defined Golgi stack
(Regoes et al. 2005; Reiner et al. 1990) although it is not clear if this is due to secondary loss as
1

a result of parasitism. What is clear is that the absence of these organelles, or their presence in
rudimentary form, does not decrease fitness within the parasite. The same cannot be said for the
host, where no benefit is gained from colonization by Giardia.

In fact, acute giardiasis

considerably reduces host fitness, and even after the infection has been cleared the evidence
suggests that there are a number of long-term effects of infection, including irritable-bowel
syndrome, chronic fatigue, and failure to thrive (Halliez and Buret 2013).

Figure 1.1: Giardia morphology
The giardial cyst (infectious stage) and trophozoite (vegetative stage). The active
trophozoite stage contains two nuclei (n) and a ventral disc (vd) and ventral flagella (vf) for
attachment. For movement the parasite relies on anterior (af), caudal (cf) and posterior flagella
(pf). The dormant cyst contains four nuclei (n) enclosed within a cyst wall (cw).

Trophozoites in the intestine swim erratically by beating their flagella and attach to
microvilli of intestinal epithelia using a suction-cup-like adhesive disc (House et al. 2011).
While attached, the flagella continue to beat, and it has been suggested that this is the cause of
the major symptoms of giardiasis: diarrhea and malabsorption (Ankarklev et al. 2010). It has
2

also been reported that Giardia secretes proteins in vitro when co-cultured with human epithelial
cells, which can result in decreased membrane function and increased permeability (Ringqvist et
al. 2008). However, no Giardia toxins capable of increasing membrane permeability have yet
been identified.
For a pathogen to be successful, it must infect as many hosts as possible, and Giardia is
no exception. However, sensitivity to oxygen and residence in the intestine pose an obstacle for
the spread of this non-invasive parasite. To circumvent this, Giardia has a biphasic life cycle—
the trophozoite is able to form a protective wall made of protein and polysaccharides by
encystation. Although it is not known what triggers encystation, the induction of cyst formation
in vitro described by Boucher and Gillin (1990) has allowed many groups to study this process
using varied and sophisticated techniques. The formation of the cyst wall and the subsequent
transformation to mature cyst takes place in the lower intestine (Adam 2001). The wall is
composed of at least three secreted proteins (CWP1-3), as well as β(1-3)-N-acetyl-dgalactosamine (GalNAc) polymer (Gerwig et al. 2002; Gottig et al. 2006; Chatterjee et al. 2010).
This appears to be a highly regulated process, in which the deposition of cyst-wall proteins
(CWP1-3) and other materials occurs through concerted trafficking of these proteins in
encystation-specific vesicles (ESV) during differentiation (Faso and Hehl 2011). Interestingly,
polysaccharides are synthesized on the external surface of plasma membranes of trophozoites,
but it is unclear when or how they are incorporated into the cyst wall. Usually, the deposition of
the cyst wall is completed by 24-hour post-induction (h.p.i.) of in vitro encystation, and it
coincides with dramatic morphologic changes as the flagellated trophozoite becomes an
aflagellate, oval-shaped cyst, which is water resistant and capable of surviving in the oxidizing
environment outside the host.
The cyst is passed by the fecal oral route, and therefore transmission is most often
associated with infected water supplies as a result of poor or no treatment practices, poor
separation of potable water and waste water lines, or communal bathing (Kramer et al. 1996;
Karanis et al. 2007). As a source of infection and a cause of disease, Giardia is an important
3

organism to study in the hope that giardiasis can be prevented through medical intervention. A
vaccine against Giardia is confounded by the expression of variable-surface proteins (VSPs),
which allow Giardia to escape host adaptive immune responses (Prucca and Lujan 2009), but
Giardia is a parasite and as such maintains only the metabolic pathways that are essential for
growth. Thus, an integral part of combating the parasite is an understanding of the pathways that
are maintained and those that have been forsaken. This provides a two-fold benefit to the study
of this protozoan. First, Giardia is an evolutionarily conserved organism, the biology of which
provides valuable insight into that of more derived organisms. Second, those pathways and
processes maintained by Giardia are likely to yield targets for fighting the infection.
1.1 The Simple Life of Giardia lamblia
The eukaryote parasite Giardia intestinalis (synonymous with G. lamblia and G.
duodenalis) is a member of the diplomonada group, which also includes free-living organisms.
The phylogenetic organization of Giardia is not clear, and it is not known whether the protist
represents an evolutionarily basal organism that diverged before the mitochondrial fusion of
higher eukaryotes or a more conserved organism with secondary loss of some organelles and
metabolic pathways due to the parasitic life-style (Hilario and Gogarten 1998; Stechmann and
Cavalier-Smith 2002). What is clear is that Giardia are minimal in a number of ways, including
the lack of common eukaryote organelles, the maintenance and processing of genetic material,
and the synthesis of proteins for both structure and metabolism.
Giardia does not possess mitochondria, and therefore it has traditionally been
characterized as among the earliest branching eukaryotes. This has been called into question
since the discovery of the mitochondria-like organelle, the mitosome (Regoes et al. 2005).
Interestingly this organelle is not known to perform any of the functions traditionally associated
with the mitochondria. No Golgi stack has been identified in Giardia. The closest to be found is
a transient Golgi network, which appears during encystation and which has been implicated in
the secretion of ESVs (Reiner et al. 1990; Stefanic et al. 2006). Rather than lysosomes, a series
4

of peripheral vacuoles (PVs) lie just below the plasma membrane. These PVs are continuous
with the tubular vesicle network (TVN), which acts as both endoplasmic reticulum (ER) and
endosome/lysosome (Abodeely et al. 2009).
The genome of this binucleate protist is compact, and it includes only four identified
introns (Morrison et al. 2007). Giardia lacks the genes necessary for the synthesis of purines
and pyrimidines, and therefore it must scavenge these from the environment. Although microaerophillic, they do not possess genes required for protection from oxidative stress, including
catalase and superoxide dismutase (Brown et al. 1995). Furthermore, Giardia has a paucity of
protein subunits for the formation of multi-meric complexes associated with a range of functions,
including initiation of DNA replication, initiation of transcription, and poly-adenylation
(Morrison et al. 2007).
1.2

Living Between Two Worlds
Infection with giardiasis can be the result of ingestion of less than 10 cysts (Talal and

Murray 1994), which usually comes from drinking contaminated water.

These cells have

survived in an oxygen-rich environment in which temperatures are considerably lower than those
found within the host. The cyst wall is constituted of 40% proteins and 60% polysaccharides,
which makes the cysts osmotically-resistant. Upon ingestion, the cells pass through the low pH
of the stomach, where it is believed that gastric acids begin to break down the wall. The process
of exiting from the cyst, excystation, is completed after the cell has traveled through the stomach
to the small intestine, where it is exposed to alkaline pH and digestive enzymes such as Trypsin.
During this process, Giardia secretes lysosomal acid phosphatase to de-phosphorylate cyst wall
proteins (Slavin et al. 2002), cathepsin B (Ward et al. 1997) to degrade these proteins, and a
specific glycohydrylase to cleave GalNAc fibrils. Once finished, the exiting cell (excyzoites)
has divided twice to produce four trophozoites.
It is in the intestine, just below the bile duct, where Giardia colonizes and causes
disease. The trophozoite beats its flagella and uses its ventral disc like a suction cup to attach
5

itself (House et al. 2011). The host mounts an innate immune response, which is in part
countered by the parasite’s consumption of arginine, limiting host-cell production of Nitric
Oxide (NO). It has also been suggested that secreted factors play a role in limiting host-cell
immune response by altering membrane function (Ringqvist et al. 2008).

Host adaptive

immunity is confounded by clonal expression of continuously changing VSPs, which allow the
parasite to evade recognition (Prucca and Lujan 2009). The final means by which Giardia
escapes host defenses is to leave, and by doing so it spreads the infection. To do this, the cell
undergoes considerable morphologic changes and forms the cyst wall. First, a transient Golgi
network is developed to secrete ESVs—which carry CWP1-3—to the cell surface.

It is

interesting that these proteins are regulated by the sterol regulatory element binding protein
(SREBP), which mediates post-translational modification of proteins through intermediates of
cholesterol metabolism. Early morphological changes such as loss of ventral disc and flagellum
cause the cell to detach from the intestinal epithelia (Lauwaet et al. 2007). This will probably
cause the cell to pass from the small intestine through the middle intestine to the large intestine
before reaching the colon. Ultimately, the cyst wall will be laid down, and it comprises the cystwall proteins, a high-cysteine non-variant cyst protein (HCNCp), giardial Myb2, cysteineprotease-2, novel cyst proteins with epidermal growth factor repeats, and Rab 11 (DuBois et al.
2008; Huang et al. 2008; Castillo-Romero et al. 2010). The remainder of the cyst wall is
composed of lipids and carbohydrates. Sixty percent of the cyst wall consists of GalNAc fibrils
(Gerwig et al. 2002) that are synthesized from fructose-6-phosphate by an unusual bacteria-like
pathway (Lopez et al. 2007; Morrison et al. 2007). Unpublished data from our laboratory
suggest that lipid comprises at least some of the cyst wall, based on the observation that FasDil,
which is a lipid staining dye, binds to the cyst wall of in-vitro-derived cysts. However, isolation
of lipids from the cyst wall for identification represents a significant challenge because in order
to isolate cyst wall strong detergents are traditionally employed. Once the cyst wall is complete,
the micro-aerophillic cell can safely survive in the oxidative environment outside of the host. As
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many as 109 cysts are shed by infected humans per day (Karanis et al. 2007) to contaminate
water supplies and thus complete the life cycle.
1.3 Lipid Synthesis and Scavenging
As stated above, Giardia colonizes the small intestine of mammalian hosts just below the
bile duct. In this complex and harsh environment, the trophozoite has access to nutrients derived
from the host diet, epithelial cells, and micro flora. Intake of these nutrients provides energy to
Giardia in two forms: (1) through the metabolism of glucose to pyruvate through the EmbdenMeyerhof-Parnas and hexose monophosphate shunt pathways (Lindmark 1980; Adam 2001), and
(2) the conversion of arginine to ornithine, producing ATP (Schofield et al. 1992). Because of
limited amino acid synthesis, the latter form of energy production competes with the host cell for
arginine, an important substrate for epithelial cell NO synthesis, which in turn limits host
defenses by reducing NO (Eckmann et al. 2000).
Apart from the glucose and arginine required for energy metabolism, Giardia is exposed
to bile salts as well as dietary lipids and free fatty acids. The effects of these nutrients have been
reported to both promote and retard Giardia growth and encystation. Fatty acids have been
shown to have anti-giardial properties (Rayan et al. 2005) and to be detrimental for growth
(Reiner et al. 1986; Das et al. 1988), and lauric acid (C12:0), for example, accumulates in
trophozoites and alters the plasma membrane integrity. Alternatively, bile acids have been
reported to promote the formation of mixed micelles, which facilitate the transport of intestinal
lipids into Giardia. Bile and fatty acids are also established inducers of in-vitro encystation, as
originally proposed by Gillin and colleagues (Gillin et al. 1986; Gillin 1987).
Lipid synthesis is limited in Giardia (Yichoy et al. 2011). Early studies using radioactive
precursors showed that acetate, glucose, glycerol, threonine, cholesterol, and glycerol-3phosphate failed to incorporate into other lipids, which provided evidence that Giardia is unable
to synthesize lipids de novo. It was therefore postulated that Giardia acquires phospholipids and
fatty acids from the culture media in vitro and from the host dietary lipids in vivo (Jarroll et al.
7

1981). This was supported by thin-layer chromatography (TLC) analysis, which showed a
similar lipid profile between the growth media and the giardial cells (Kaneda and Goutsu 1988;
Mohareb et al. 1991).

Using quadrupole time-of-flight (qTOF) mass spectrometry, our

laboratory has identified only lyso-phosphatidylcholine (lyso-PC) and phosphatidylcholine (PC)
in

the serum and bile,

which

suggests

that

the phosphatidylglycerol

(PG) and

phosphatidylethanolamine (PE) found in giardial cells were being synthesized by the parasite
(Yichoy et al. 2009). We have proposed that these phospholipids could be generated via the
fatty acid and head-group remodeling pathways by passing the CDP-DAG (de novo) pathway
(Das et al. 2001). The support for this hypothesis is twofold. First, radio labelled fatty acids are
readily incorporated into membrane phospholipids (Blair and Weller 1987; Stevens et al. 1997;
Gibson et al. 1999; Vargas-Villarreal et al. 2007), and second, radiolabeled choline,
ethanolamine, inositol, serine, and glycerol are readily incorporated into respective
phospholipids in trophozoites when these bases are added to the culture media (Das et al.,
unpublished). It follows that lipid neogenesis in Giardia is likely to be more often the result of
fatty acid remodeling/head-group exchange than the result of the Lands cycle.
Scavenging of lipids is likely to provide an abundant source of lipids, as well as substrate
for conversion to the lipids required by the organism. Using fluorescent analogues, our lab has
shown that Giardia readily ingests and incorporates lipids throughout the cell.

Cellular

localization studies indicate that cellular targeting is distinct between lipid classes, which suggest
at least some role for active transport of these lipids in and out of the cell. For example, although
PC incorporates into the plasma membrane and flagella, sphingomyelin (SM), which also
possesses the choline headgroup labels that the nuclear envelope and plasma membrane similar
to palmitic acid (PalmA). PG and ceramide (Cer) both label the perinuclear membrane, and PE
localizes to the plasma membrane and the discrete cytoplasmic structures just below the
membrane (Stevens et al. 1997; Gibson et al. 1999; Das et al. 2001).
The mechanism by which lipids are incorporated into the cell varies between active and
passive transport. Intracellular trafficking of Cer and SM was shown by our lab to be blocked by
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the actin depolymerizing drug cytochalasin-D, which suggests that these lipids are endocytosed
through cytoskeletal-dependent processes (Hernandez et al. 2007; Castillo-Romero et al. 2010).
We reported that ceramide is internalized by clatherin-coated vesicles, which target the
perinuclear membrane, and that the microtubule depolymerizing drugs also block the release of
PG from the ER, which suggests that not only intake but also the transport of this lipid is
cytoskeleton dependent.

In contrast, neither PC nor palmitic acid was affected by anti-

cytoskeletal agents, which suggests that the intake of these is not dependent upon the
cytoskeleton for trafficking (Castillo-Romero et al. 2010).
1.4 OF Sphingolipids and Encystation
When the Giardia genome project was finished, it was possible to gain access to a
plethora of information about the giardial genome as described above. Our lab’s interest in lipids
led us to investigate genes related to lipid metabolism in Giardia, and soon we identified an asyet-undescribed gap in the metabolism of the highly bioactive sphingolipids (SLs). SLs are (1)
lipids with a sphingosine base and an amide-linked fatty acid chain that are both structural as
components of detergent-resistant membrane (DRM) microdomains, and (2) functional as
important signaling molecules (Hannun and Obeid 2008; Lingwood and Simons 2010).
According to data mining in the genome, Giardia is quite limited in the de novo synthesis and
metabolism of SLs. Giardia maintains two copies of the enzyme responsible for the first
committed step of SL synthesis—serine palmitoyltransferase (gSPT1 and gSPT2) and
glucosylceramide transferase (gGlcT1 or GCS). Evidence for the metabolism of SLs is slightly
more scarce, with two copies of an acid sphingomyelinase-like phosphodiesterase 3b precursor
(gASMLPD3b1 and gASMLPD3b2). From this, it may seem that SL metabolism simply is not
required by the parasite, but recent reports by our laboratory and others suggest that these genes
are important for both giardial growth and encystation. Expression profiles using serial analysis
of gene expression (SAGE), microarray, and quantitative real-time polymerase chain reaction
(qRT-PCR) all indicate a differential transcription of giardial SL metabolic genes during cyst
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formation (Hernandez et al. 2008; Birkeland et al. 2010; Morf et al. 2010).

In addition,

treatment of trophozoites with L-cycloserine, an inhibitor of SPT, has been shown to interrupt
ceramide uptake and targeting (Hernandez et al. 2008). D-threo-1-phenyl-2-decanoylamino-3morpholino-1-propanol (PPMP), a potent and specific inhibitor of GCS, was shown to inhibit
growth and encystation of giardia cells in culture (Hernandez et al. 2008; Sonda et al. 2008;
Stefanic et al. 2010). Finally, both overexpression and knockdown of gGlcT1 disrupt viable cyst
production (Mendez et al. 2013), and it appears that it is a balance of SL that is important
because both increases and decreases in production lead to similar reductions in cyst formation.
Taken together these data identify a clear requirement for SLs in order to complete the life cycle
of G. lamblia.
1.5 Knowledge Gap and Aims of the Current Dissertation
The connection between gGlcT1 activity and encystation has been demonstrated, but it
remains unclear whether this link is mediated by the enzyme itself, the lipid product, or both. In
that same vein, although Giardia requires SLs and is to some extent able to modulate these
molecules, it is not known if this represents a structural requirement, a signaling pathway, or
both. The assumption that the majority of lipids are taken up from the environment can be
reasonably extended to include SLs, but because Cer and SM uptake involves the cytoskeleton
this is likely to be a regulated process that could potentially be selective. Early reports using
thin-layer chromatography have suggested that the lipid profile of the growth media and Giardia
trophozoites are similar, yet given the limitations of this technique it remains to be seen how
“similar is similar”—i.e., are all classes of SLs found in the media represented in the Giardia
profile, are the species of each class similar, and are there any classes/species of SL that are over
or under-represented in the cell. A global SL profile, sphingolipidome, of Giardia has not been
established conclusively and the ways that these lipids are modulated during encystation has not
yet been established.
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My dissertation focuses on characterizing the sphingolipidome of Giardia throughout its
life cycle. I found that Cer and SM are the major SLs in this parasite and that their levels are
altered during encystation.

In addition, glycosphingolipids (GSLs), like monohexosyl-,

dihexosyl-, and trihexosyl ceramides, are also present and elevated in encysting Giardia.
Interestingly, viable cysts contain higher SM concentrations than non-viable cysts and efficiently
undergo excystation in vitro. I also show that gASMLPD3b1 and gASMLPD3b2 are both
functional and that over-expression of gASMLPD3b1 reduces in vitro excystation efficiency.
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Chapter 2: Sphingolipidomics of Giardia lamblia
Sphingolipids (SLs) are both important structural components of plasma membranes and active
signaling molecules implicated in cellular processes as varied as growth, differentiation,
apoptosis, senescence and autophagy (Venable et al. 1995; Ogretmen and Hannun 2004; Scarlatti
et al. 2004). Whereas early work has focused upon the role of entire classes of SLs in cellular
processes and disease states, it is now increasingly recognized that for ceramide and SM there is
evidence that each molecule is functionally distinct based upon both acyl chain length and degree
of unsaturation (Ben-David and Futerman 2010; Grosch et al. 2012; Slotte 2013).
Metabolism of SLs occurs primarily in eukaryotes but has also been reported in some
bacteria such as sphingomonas spp (Hannun and Obeid 2008).

The synthesis of these lipids

begins with the condensation of L-serine and palmitoyl-Coa (or myristate or stearate) to form 3keto-sphinganine (3KS), which is subsequently reduced to sphinganine by 3-keto sphinganine
reductase (3KSR) followed by acylation via either ceramide synthase or dihydroceramide
synthase (Lass or CerS) to form dihydroceramide. Formation of Cer occurs upon desaturation of
dihydroceramide.

Once formed Cer becomes the backbone upon which complex SLs are

formed. This is accomplished through glycosylation by glucosylceramide or galactosylceramide
synthase (GlcT1/GCS), phosphorylation by ceramide kinase (CerK) or addition of a
phosphocholine by SM synthase to form SM. The latter reaction produces diacylglycerol (DAG)
from PC, highlighting the interconnected nature of SL metabolism and other lipid metabolic
pathways.
Once formed, these lipids are broken down by specific hydrolases; Cer is produced
through the hydrolysis of SM by SMase and glucosylceramide and galactosylceramide by
specific β-glycosidases. Cleavage of the acyl chain from Cer produces sphingosine which can
then be recycled for the formation of Cer or phosphorylated to sphingosine-1-phosphate. Exit
from the SL pathway is carried out by sphingosine-1-phosphate, which is dephosphorylated by
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sphingosine-phosphate phosphatase or irreversibly cleaved to ethanolamine and hexadecanal
(Futerman and Riezman 2005; Hannun and Obeid 2008).

Figure 2.1: Sphingolipid metabolic pathway
SL enzymes are boxed; red boxes indicate enzymes not identified in Giardia, green boxes
indicate those that were. Structures are representative, acyl chain and sphingoid base can vary in
number of carbons.
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As mentioned above, SL metabolism in Giardia is both fragmented and incomplete. In
the genome database (www.giardiaDB.org) there are only five identified SL genes, and due to
redundant

pairs,

palmitoyltransferase

there

are

(gSPT1

only three
and

SL metabolic

gSPT2),

functions.

sphingomyelinase

They are

(gASMLPD3b1

serine
and

gASMLPD3b2) and glucosylceramide synthase (gGlcT1). There are no apparent enzymes for
the de-novo synthesis of sphingosine or Cer, nor are there any SL specific kinases capable of the
formation of ceramide-1-phosphate or sphingosine-1-phosphate.

However this does not

preclude the possibility that these functions could be mediated through either a novel pathway or
by enzymes with less than significant sequence similarity. Therefore, it is unclear the types of
SLs that are present in Giardia and whether they are capable of synthesizing new SL molecules,
or if SLs are simply scavenged from the environment. Based upon the assumption that Giardia
has the ability to glycosylate Cer as well as generate Cer through hydrolysis of SM, I asked if the
parasite was capable of other manipulations of these lipids not predicted by the genome. To
approach this problem I performed a mass spectrometry based investigation into the SLs present
in the cell as well as the media. I also investigated the presence/absence of SLs throughout the
Giardia life cycle to identify stage specific regulation of these important molecules
2.1

MATERIALS AND METHODS

2.1.1 Materials
Unless otherwise specified, all chemicals were purchased from Sigma and were of the
highest purity available. All solvents used for mass spectrometry were of LC/MS grade.
Fluorescent (Bodipy- or NBD-conjugated) lipids were purchased from Invitrogen. N-palmitoyld31-D-erythro-sphingosine

(deuterated

ceramide)

and

N-palmitoyl-d31-D-erythro-

sphingosylphosphorylcholine (deuterated sphingomyelin) as well as all other sphingolipid
standards were obtained from Avanti Polar Lipids (Alabaster, AL). Sphingomyelin [choline
methyl-14C] (bovine, 50-60 mCi/mmol) was purchased from American Radiolabeled Chemical
(St. Louis, MO).
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2.1.2 Parasite, encystation and excystation
Giardia lamblia trophozoites (assemblage A, strain WB C6), ATCC No. 30957) were
cultivated following the method of Diamond et al. (Diamond et al. 1978) using modified TYI-S33 medium supplemented with 10% adult bovine serum and 1% bovine bile (Keister 1983). The
antibiotic piperacillin (100 μg/ml) was added during routine culturing of the parasite (Gillin et al.
1989). Trophozoites were detached from the culture flask by ice chilling and harvested by
centrifugation at 1500 × g for 10 min at 4 °C, followed by three washings in sterile phosphatebuffered saline (PBS) and microscopic determination of cell numbers using a hemocytometer.
In- vitro encystation was carried out by culturing the trophozoites in TYI-S-33 medium, pH 7.8,
supplemented with adult bovine serum (10%, v/v), lactic acid (5 mM), and porcine bile (250
mg/ml) for various time points, as described previously (Gillin et al. 1989). Cells were allowed
to encyst for 72 h, and cysts were isolated by centrifugation (2,500 × g for 10 min at 4 °C),
washed three times in cold distilled water, and kept in water for 1 hour at 4°C. Isolated waterresistant cysts were counted or subjected to the microscopic experiments also described below.
Excystation was carried out by two step method described previously (Boucher and Gillin 1990).
Briefly, 2 x 106 cysts were exposed to strong acid for 1 h to mimic stomach conditions followed
by culture in alkaline pH with trypsin to mimic conditions seen in the intestine. Cells were then
allowed to recover in culture media and monitored for growth for 72 h in some experiments cells
were counted after 72 hours.
2.1.3 Lipid Extraction
Cultured Giardia trophozoites (1x108cells) were harvested and transferred to 13 x150mm
borosilicate glass tubes with polytetrafluoroethylene (PTFE) caps. These cells were washed
twice with PBS and pelleted by centrifugation (1500 × g, 5 min). Cells were re-suspended in
1ml PBS and, following removal of 100uL aliquot for protein quantitation by Bradford assay, the
remaining cells were lyophilized, flushed with N2 and stored at -80 °C until extraction. This
same procedure was carried out for cells 12 and 24 hours post induction of encystation (h.p.i).
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Cysts were harvested after 72 h.p.i. then washed and re-suspended in cold distilled H2O for 1 h
prior to lyophilization.

Lipids were also extracted from 1 ml bovine serum, bovine bile

(52mg/ml) and porcine bile (50mg/ml) following the same extraction procedure. Each was
lyophilized prior to extraction as with cell pellets. Freeze dried samples were re-suspended in
MeOH to 1mg/mL protein.

An aliquot equivalent to 1mg protein was removed to clean

borosilicate glass tube and dried under N2 stream. This was then resuspended in CHCl3: MeOH
(2:1,v,v) and incubated at 48 °C overnight. To remove possibly interfering glycerophospholipids,
samples were treated with 100mM (final concentration) KOH for 2 hours at 37 °C. They were
then allowed to cool to room temperature and pH was adjusted to 4-5 with glacial acetic acid
(Sullards et al. 2007). Samples were centrifuged (900 x g, 5min) and supernatant was transferred
to

clean tube.

SLs in

the remaining pellet

were then

extracted twice

with

Isopropanol:Hexane:H2O 55:25:20 v,v,v and finally with CHCl3:MeOH 1:1 v,v (Li et al. 2008).
Extracts were pooled and dried either under N2 stream or in centrivap vacuum centrifuge.
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2.1.4 Qualitative Lipidomics

Figure 2.2: Flow chart for qualitative sphingolipidomics method
Glycosphingolipids
Separation of acidic and neutral GSLs and removal of non-GSL impurities from neutral
glycosphingolipid fraction was carried out as described previously (Li et al. 2008) with the
following modifications.
DEAE Chromatography
0.5g DEAE-Cl resin (Sigma-Aldrich) was swelled overnight in 10ml 0.5M NaOAc in
CHCl3:MeOH:H2O 30:60:8 (lower phase.) Processed resin (1ml) was then packed onto a Pasteur
pipette over a small amount of glass wool. The resin was washed with 10 bed volumes (10ml)
CHCl3:MeOH:H2O (lower phase) and samples were loaded in the same solvent. Neutral lipids
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were eluted with 5ml of the same solvent and acidic lipids were eluted with 5 ml of 0.8M
NaOAc in MeOH. Eluates were dried as before, re-suspended in H2O and desalted using a 3ml
DSC-18 SPE cartridge (Supelco), dried and stored at -20 °C under N2 until further processing.
Neutral lipids were then per-N-acetylated with 4ml acetic anhydride and 2ml pyridine in the dark
overnight then dried in centrivap.
Florisil Fractionation
To remove non-GSL impurities Florisil columns were prepared in Pasteur pipettes using
a small amount of glass wool and 300mg of Florisil resin (60 mesh, Sigma-Aldrich). The resin
was washed with 10ml dichloroethane (DCE):acetone 1:1 v,v, then 10ml DCE, and finally
equilibrated with 10ml hexane:DCE 1:4 v,v. Samples were loaded in this solvent. Fraction F1
was eluted with 10ml hexane:DCE 1:4 v,v; Fraction F2 was eluted with 10ml DCE and Fraction
F3, which is rich in GSLs, was eluted with DCE:acetone 1:1 v,v. Extracts were dried in
centrivap and acetylated with 3ml 0.5N NaOMe in 6ml MeOH for 2 hours at room temperature.
The reaction was stopped with 2ml 10% acetic acid in MeOH (pH 4-5) desalted as mentioned
above, dried and stored under N2 at -20 °C.
Per-N,O-Methylation of glycosphingolipids
Neutral GSL’s from Florisil fraction F3 and acidic GSL’s from DEAE eluate were
methylated as described by Ciucanu and Kerek (Ciucanu 1984).

Briefly GSLs were re-

suspended in 150μL DMSO, 40-50 mg of NaOH was added and stirred until dissolved. The
reaction was started by adding 80µl iodomethane and vortexed for 1h at room temperature. The
reaction was quenched with 2ml H2O and GSLs were then extracted with dichloromethane
(DCM). Extracts were washed with H2O, dried under N2, re-suspended to 1mg/ml protein in
MeOH and analyzed by nano-ESI mass spectrometry.
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Sphingoid bases, sphingomyelins and ceramides
To identify SM species samples were extracted as described above.

Extracts were

partitioned by the Folch method (Folch et al. 1957). The lower chloroform phase was dried
under N2 and re-suspended in 500 µl MeOH and stored at -80 °C. An aliquot of this was
removed for identification of Cer, the remainder was processed further for the identification of
sphingoid bases and SM species. To ensure the complete removal of glycerophospholipids that
could interfere with data interpretation (especially PC), samples were subjected to alkaline
hydrolysis as described previously (Jiang et al. 2007). Briefly lipid extract was re-suspended in
200µl lithium methoxide in methanol (1M, Sigma-Aldrich), vortexed for 15 seconds then
incubated at 0 °C for 1 h. Reaction was stopped with 0.4% glacial acetic acid (2ml), and pH was
adjusted to 4-5. Aqueous solution was washed with 2ml hexane, then lipids were extracted by
Folch partition. Lower chloroform phase was washed, with 50mM lithium chloride solution,
dried under N2, re-suspended in 500µl MeOH and stored at -80 °C until further analysis.

Ion Trap nano ESI MS/MS analysis
Analyses were carried out in positive ion mode on a linear triple quadrupole mass
spectrometer (LTQ, thermo fisher). Samples were infused directly via Advion [Ithaca, NY]
TriVersa NanoMate chip interface (capillary temperature 230°C), with injection time 100.00 ms,
activation time 30 ms, activation Q-value, 0.250, isolation width m/z 2.0. Extracts from each
fraction were diluted to 100fmols/µl protein equivalent and directly infused into the mass
spectrometer. To improve ionization of samples that had not been methylated, 5mM LiOH was
added. Full scans were recorded for ~1 minute in profile mode for each fraction in triplicate and
Total Ion Mapping (TIM) was carried out over the mass range for analytes expected from each
fraction. For ion mapping 3 µscans were taken with a mass interval of 2.0 and collision energy
of 35kV. Ion mapping from each fraction was used to determine presence of SL species by
looking for characteristic neutral loss or product ion masses.
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For example methylated

hexosylceramide species produce a characteristic product ion at m/z 258.6 corresponding to
[methylated hexose +Na], dihexosylceramide produces a peak at 463.4 [(methylated hexose)2
+Na], SM with a lithium adduct can be found with neutral loss of 59 [N(CH3)3], for a complete
list of TIM fragments used see Table 2.1 and 2.2. For structural validation, putative SL species
identified from ion mapping were fragmented further (ms3 to ms5 depending on analyte
abundance) to confirm sphingoid base and fatty acyl chain length. All files were acquired using
Xcalibur software.

2.1.5

Sphingolipid Quantitation

Due to the high concentration of SM in Giardia extracts, SLs extracted above were
separated as described previously (Pernet et al. 2006) off-line, prior to on-line HPLC. Briefly,
~200 mg Silica gel (60A, Sigma-Aldrich) was poured into a Pasteur pipette, washed with 10ml
MeOH followed by 10ml of acetone before equilibrating with 10ml CHCL3. Samples equivalent
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Figure 2.3: Flow chart with quantitative sphingolipidomics methods

to 1mg of protein were loaded onto column in 1mL CHCl3. Neutral lipids (hydrocarbons, sterols)
were eluted with 10ml CHCl3, followed by glycolipids and ceramides with 10ml of acetone and
finally phospholipids were eluted with 10ml MeOH. All fractions were dried under N2 then resuspended in methanol to an equivalent of 100fmol/µl protein and stored at -80 °C until further
use.
HPLC
Reverse phase high pressure liquid chromatography (HPLC) was performed using a
nano-capillary column, slurry packed in the laboratory (0.075mm x 100mm, C8 resin 3μm beads
Pinnacle II Restek Corp.). Solvent A: 30:70 acetonitrile:H2O with 10mM ammonium formate
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and 0.2% formic acid.

Solvent B: 90:10 isopropanol: acetonitrile with 10mM ammonium

formate and 0.02% formic acid. Sample (1 μl) (100fmol protein equivalent) was spiked with
100fmol deuterated d18:1/16:0 SM (d31) and 100 fmol deuterated d18:1/16:0 Cer (d31) then
loaded onto column in 70/30 A/B. Gradient began at 30%B for 10 minutes followed by a ramp
from 30% B to 80%B over 5 minutes, plateaued at 80%B for 2minutes, then ramp from 80%B to
99%B over 25minutes. This was followed by 10 minutes at 99%B then a return to starting
conditions over 5minutes and equilibration for an additional 38 minutes.

Fourier Transform nano ESI MS/MS
Samples were analyzed by high resolution mass spectrometry (QExactive, Thermo
Fisher). Data were collected by select ion monitoring (SIM) with resolution of 70,000 as well as
targeted ms2 (tMS2) with resolution of 35,000 from inclusion list containing species identified
previously (see qualitative mass spectrometry above). SIM chromatograms were filtered for
exact mass of species of interest and peak detection and integration were performed using
Xcalibur v2.1 processing software (ISCIS detection, mass tolerance 5ppm, smoothing 7, baseline
window 40, area noise factor 10, peak noise factor 20, minimum peak height S/N 3). Integrated
peak areas were divided by integrated area of internal standard peak (D31 d18:1/16:0 Cer for
ceramides and glycosphingolipids and D31 d18:1/16:0 SM for SM species) and response ratio
was plotted on linear calibration curves to give absolute concentration of SL. Curves were
generated by LC MS/MS using increasing concentrations of standards while maintaining
100fmol/μl D31 Cer or D31 SM followed by peak integration, calculation of response ratio and
linear regression. I found that response ratios vs. D31 Cer under these conditions for medium to
long chain ceramide, glucosylceramide and lactosylceramide were very similar and therefore all
were plotted together to generate linear equation used for the calculations of these species. SM
curve was constructed separately. Each sample was run in triplicate and the result recorded as
mean plus standard error (n=3). Each species was confirmed by analyses of simultaneous tMS2
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to identify characteristic fragment peaks (264.2686 and 266.2842 for d18:1 and d18:0 sphingoid
bases respectively as well as 184.0733 for SM choline). Final result was given as pmol/cell
using protein standard curves generated from 104, 105, 106 and 107 cells.

2.1.6 Statistical Analyses
All results are given as mean ± SE (n=3), and statistical analyses were generated using
Sigma Plot software version 12.0 (Systat Software Inc. San Jose, CA). In all experiments
student t-tests were performed and statistical values less than 0.05 were considered significant.
2.2

RESULTS

2.2.1 Shotgun sphingolipidomic analysis
The process of encystation and cyst formation is critical for the survival of Giardia
outside of the host intestine. Previously we have shown that the modulation of glucosylceramide
influences the biogenesis of ESVs and cyst viability, indicating that glucosylceramide and other
SLs play important role for proper cyst formation. Interestingly, the SL metabolic pathway in
Giardia is limited to two copies of serine palmitoyltransferase (gSPT1 and gSPT2), two copies
of a sphingomyelinase like phosphodiesterase (gASMLPD3b1 and gASMLPD3b2) and a single
copy of glucosylceramide transferase-1 (gGlcT1) (Hernandez et al. 2008).

Given this

incomplete and disjointed pathway we thought it likely that SLs were being taken up from
sources within the culture media (specifically bovine serum). However it was not known how
these lipids would be manipulated by the parasite or the fate of scavenged lipid during the
process of encystation and cyst formation. To investigate this, we conducted shotgun
sphingolipidomics by direct infusion via chip based nano-ESI on a linear triple quadrupole ion
trap mass spectrometer (LTQ Thermo Fisher).
Infused samples were subjected to total ion mapping and then queried for characteristic
ion fragments i.e. neutral loss or parent daughter mass transitions. We found that per-N,Omethylated GSL species could be readily identified by a predominant glycan peak (figure 2.423

2.5, Table 2.1 and 2.2). Per-N,O-methylated ceramide could be distinguished by neutral loss of
48 Da as well as a prominent peak at 278.6 (for d18:1 sphingoid base containing species).
Interestingly, on our instrument under these conditions we found that fragmentation of lithiated
Cer (not methylated) which generate a well characterized peak at 264.2 did not yield many
species. Perhaps due to the low abundance of these, we found that per-N,O-methylation of Cer
greatly increased the number of species we could identify. SM in the presence of 5mM LiOH
was identified by a neutral loss of 59 Da.
.

Figure 2.4: Total Ion Map of Giardia lamblia SL extracts
A, B, C. per-N,O-methylated Florisil Fraction 3 filtered for 259 (Hexose+Na), 463
(Hexose2 +Na) and 667 (Hexose3 +Na) respectively. D. DEAE acid fraction filtered for Neutral
fragment of 376 Daltons (Sialic acid).

Further characterization and confirmation was carried out by analyzing ms(n)
fragmentation following the in-depth studies reviewed by Levery, for GSLs (Levery 2005) as
well as Hsu and Turk’s work with lithiated SM (Hsu and Turk 2000). We identified ceramide,
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hexosylceramide, dihexosylceramide, trihexosylceramide, SM, HexNAc-trihexosylceramide and
HexNAc-tetrahexosylceramide among neutral SLs (please see Table 2.1 and 2.2 for species and
mass filters). The majority of these species consisted of d18:1 sphingosine backbones and acyl
chains ranging from C14 to C24. Acidic species identified were d18:1/C14-C24 GM3 (monosialo dihexosylceramide, d18:1/C14-C24 GD3 (di-sialo dihexosylceramide) and d18:1/16:0 and
d18:1/18:0 GM1 (mono-sialo HexNAc trihexosylceramide). Extracts from trophozoites, 12
h.p.i, 24 h.p.i, cysts and bovine serum all showed similar profiles. From extracts of bovine bile
as well as well as porcine bile we identified Cer and SM species but no GSLs were found in
these samples. Given the lack of Cer synthase and SM synthase in the Giardia genome database
(www.giardiadb.org), our analyses indicate that the majority of these SLs are scavenged from the
culture media by trophozoites
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Figure 2.5: Representative fragmentation analysis of a neutral glycosphingolipid
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Figure 2.6: Representative fragmentation analysis of an acidic glycosphingolipid
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Table 2.1 Acidic sphingolipids identified in this study:
Sphingolipid Species

[M+Na]+

TIM Filter

d18:1/26:0 GM3

1512

NL 376

d18:1/25:0 GM3

1498

NL 376

d18:1/24:0 GM3

1484

NL 376

d18:1/23:0 GM3

1470.8

NL 376

d18:1/22:0 GM3

1456.8

NL 376

d18:1/21:0 GM3

1442.8

NL 376

d18:1/20:0 GM3

1428.8

NL 376

d18:1/19:0 GM3

1414.8

NL 376

d18:1/18:0 GM3

1400.8

NL 376

d18:1/18:1 GM3

1398.8

NL 376

d18:1/17:0 GM3

1386.8

NL 376

d18:1/17:1 GM3

1384.8

NL 376

d18:1/16:0 GM3

1372.8

NL 376

d18:1/16:1 GM3

1370.8

NL 376

d18:1/15:0 GM3

1358.8

NL 376

d18:1/14:0 GM3

1344.8

NL 376

d18:1/26:0 Gd3

1874

NL 376

d18:1/25:0 Gd3

1860

NL 376

d18:1/24:0 Gd3

1846

NL 376

d18:1/23:0 Gd3

1832

NL 376

d18:1/22:0 Gd3

1818

NL 376

d18:1/21:0 Gd3

1804

NL 376

d18:1/20:0 Gd3

1790

NL 376

d18:1/19:0 Gd3

1776

NL 376

d18:1/18:0 Gd3

1762.19

NL 376

d18:1/17:0 Gd3

1748.19

NL 376

d18:1/16:0 Gd3

1734.19

NL 376

d18:1/15:0 Gd3

1720.19

NL 376
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d18:1/16:0 GM1

1822

BP 1273

d18:1/18:0 GM1

1850

BP 1273

Table 2.2 Neutral sphingolipids identified in this study
Sphingolipid Species

[M+Na]+

TIM Filter

D18:1/26:0 HexNAc-(Hexose)3-Cer

1590.0

NL 260

D18:1/25:0 HexNAc-(Hexose)3-Cer

1586.0

NL 260

D18:1/24:0 HexNAc-(Hexose)3-Cer

1572.0

NL 260

D18:1/23:0 HexNAc-(Hexose)3-Cer

1558.0

NL 260

D18:1/22:0 HexNAc-(Hexose)3-Cer

1544.0

NL 260

d18:1/21:0 HexNAc-(Hexose)3-Cer

1530.0

NL 260

d18:1/20:0 HexNAc-(Hexose)3-Cer

1516.0

NL 260

d18:1/19:0 HexNAc-(Hexose)3-Cer

1502.0

NL 260

d18:1/18:0 HexNAc-(Hexose)3-Cer

1488.0

NL 260

d18:1/17:0 HexNAc-(Hexose)3-Cer

1474.0

NL 260

d18:1/16:0 HexNAc-(Hexose)3-Cer

1460.0

NL 260

d18:1/15:0 HexNAc-(Hexose)3-Cer

1446.0

NL 260

d18:1/24:0 Hexose-HexNAc-(Hexose)3-Cer

1734.0

NL260

d18:1/20:0 Hexose-HexNAc-(Hexose)3-Cer

1706.0

NL260

d18:1/18:0 Hexose-HexNAc-(Hexose)3-Cer

1678.0

NL260

d18:1/16:0 Hexose-HexNAc-(Hexose)3-Cer

1650.0

NL260

d18:1/14:0 trihexosylceramide

1186.0

BP 667

d18:1/15:0 trihexosylceramide

1200.0

BP 667

d18:1/16:0 trihexosylceramide

1214.0

BP 667

d18:1/17:0 trihexosylceramide

1228.0

BP 667

d18:1/18:0 trihexosylceramide

1242.0

BP 667

d18:1/19:0 trihexosylceramide

1256.0

BP 667

d18:1/20:0 trihexosylceramide

1270.0

BP 667
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d18:1/21:0 trihexosylceramide

1284.0

BP 667

d18:1/22:0 trihexosylceramide

1298.0

BP 667

d18:1/23:0 trihexosylceramide

1312.0

BP 667

d18:1/24:0 trihexosylceramide

1326.0

BP 667

d18:1/25:0 trihexosylceramide

1340.0

BP 667

d18:1/26:0 trihexosylceramide

1354.0

BP 667

d18:1/14:0 dihexosylceramide

982.7

BP 463

d18:1/15:0 dihexosylceramide

996.7

BP 463

d18:1/16:1 dihexosylceramide

1008.6

BP 463

d18:1/16:0 dihexosylceramide

1010.7

BP 463

d18:1/17:0 dihexosylceramide

1024.8

BP 463

d18:1/18:0 dihexosylceramide

1038.8

BP 463

d18:1/19:0 dihexosylceramide

1052.8

BP 463

d18:1/20:0 dihexosylceramide

1066.8

BP 463

d18:1/22:0 dihexosylceramide

1094.8

BP 463

d18:1/23:0 dihexosylceramide

1108.9

BP 463

d18:1/24:1 dihexosylceramide

1120.9

BP 463

d18:1/24:0 dihexosylceramide

1122.9

BP 463

d18:1/14:0 Hexosylceramide

778.6

BP 259

d18:1/15:0 Hexosylceramide

792.6

BP 259

d18:1/16:0 Hexosylceramide

806.6

BP 259

d18:1/17:0 Hexosylceramide

820.7

BP 259

d18:1/18:0 Hexosylceramide

834.7

BP 259

d18:1/19:0 Hexosylceramide

848.6

BP 259

d18:1/20:0 Hexosylceramide

862.6

BP 259

d18:1/21:0 Hexosylceramide

876.6

BP 259

d18:1/22:0 Hexosylceramide

890.6

BP 259

d18:1/23:0 Hexosylceramide

904.6

BP 259

d18:1/24:1 Hexosylceramide

916.8

BP 259

d18:1/24:0 Hexosylceramide

918.8

BP 259

d18:1/14:0 Ceramide

574.5

NL 30
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d18:1/15:0 Ceramide

588.5

NL 30

d18:1/16:0 Ceramide

602.5

NL 30

d18:1/17:0 Ceramide

616.6

NL 30

d18:1/18:0 Ceramide

630.6

NL 30

d18:1/19:0 Ceramide

644.6

NL 30

d18:1/20:0 Ceramide

658.6

NL 30

d18:1/22:0 Ceramide

686.6

NL 30

d18:1/23:0 Ceramide

700.7

NL 30

d18:1/24:1 Ceramide

712.7

NL 30

d18:1/24:0 Ceramide

714.7

NL 30

[M+Li]+
d18:1/15:0 sphingomyelin

695.6

NL 59

d18:1/16:0 sphingomyelin

709.6

NL 59

d18:1/17:0 sphingomyelin

723.6

NL 59

d18:1/18:0 sphingomyelin

737.6

NL 59

d18:1/19:0 sphingomyelin

751.6

NL 59

d18:1/20:0 sphingomyelin

765.6

NL 59

d18:1/22:0 sphingomyelin

793.7

NL 59

d18:1/23:1 sphingomyelin

805.6

NL 59

d18:1/23:0 sphingomyelin

807.7

NL 59

d18:1/24:1 sphingomyelin

819.7

NL 59

d18:1/24:0 sphingomyelin

821.7

NL 59

d18:1/26:0 sphingomyelin

849.7

NL 59

2.2.2 Quantitation of Sphingolipids
The limitation of our exploratory approach (described above) by direct infusion is the
inability to quantitate the abundance of each species. This is due in part to ion suppression,
which can be very high in these complex mixtures, as well as the failure to differentiate isobaric
species. Furthermore, incomplete per-N,O-methylation could potentially inflate the number of
species identified. To bypass this, we analyzed neutral sphingolipids by tandem nano HPLC31

MS/MS on a bench top orbitrap mass spectrometer (QExactive, Thermo fisher). Due to large
differences in SM concentration vs. Cer and GSL abundance, samples were separated off-line
using a silica 60 column prepared in a Pasteur pipette as described in 2.1.5. After verifying
individual SLs by retention time and targeted MS-2 fragmentation (Fig 2.7), Select Ion
Monitoring (SIM) scans were used for quantitation (Fig 2.8).

Figure 2.7: Identification of sphingolipids for quantitation by fragmentation and exact mass
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Figure 2.8: Representative extracted ion chromatograms used for SIM.
Calibration curves were generated to ensure that this method is linear and efficiently
identifies the ionization differences. We found that carbon chain length in the standards analyzed
had little effect on the response ratio to internal standard. Furthermore, response ratios for
ceramides and glycosylceramides were similar enough to plot all data on a single graph (Fig. 2.9)
To quantitate respective lipids, the integrated area of extracted ion chromatograms for each SIM
reaction was divided by the integrated area of the extracted ion chromatogram for a stable
isotope labeled internal standard (D31 d18:1/16:0 SM for SM samples, D31 d18:1/16:0 Cer for
ceramides and glycosylceramides) to generate a response ratio using the processing software in
Xcalibur v2.1. Concentrations were calculated from these response ratios using linear equations
generated from calibration curves. This method allowed us to analyze SL extracts from
trophozoites, two time points during encystation (12 and 24 h.p.i.) and cysts.
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Further

quantitation was performed for the culture media sources of SLs (bovine bile and bovine serum)
and the encysting media sources of SLs (bovine serum and porcine bile).

Figure 2.9: Calibration curves used for quantitation of SLs
LC-MS/MS high resolution mass spectrometry in both Select Ion Monitoring and ms2
modes allowed us to identify two other much less abundant sphingoid bases, d18:0 and d18:2.
Further differences included identification of GSLs in both bovine and porcine bile as well as
longer chain fatty acids, including C25 and C26 in all samples. This method, however, failed to
identify the HexNAc containing GSLs. This could be due to differences in extraction procedures
between the two methods used in the current study.
2.2.3 Neutral SLs are Abundant in Encysting Giardia
Although the overall SL profile remained mostly unchanged during encystation the
proportion of each species (sphingoid base/acyl chain combination in each class) of lipid differed
between the cell and the media that cell was grown in (Fig. 2.10-2.14).
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Based upon the

assumption that passive uptake would lead to identical profiles between cell and media, this
observation indicates either selective uptake from the media or evidence of the parasites ability
to modify these lipids once they have been scavenged from the culture environment.

Figure 2.10: Percent composition of sphingomyelin
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Figure 2.11: Percent composition of ceramide
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Figure 2.12: Percent composition of hexosylceramide
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Figure 2.13: Percent composition of dihexosylceramide
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Figure 2.14: Percent composition of trihexosylceramide
To investigate changes in SLs by class, I used the total abundance given by the sum of
the species in that class for each time point analyzed. I found that the levels of Cer and GSLs all
increase during cyst formation.

Within 24 h.p.i., Cer increases 10 fold; hexosylceramide,

dihexosylceramide and trihexosylceramide increase between 11 and 12 fold. (Fig 2.15A and
2.15C). Each of these then decrease in cysts although remain slightly above trophozoite levels.
Interestingly, total SM decreases 5 fold by 12 h and then increases, with cyst levels 3 fold greater
than trophozoites (Fig. 2.15B). When these data are normalized by protein concentration this
increase is greater than 40 fold (not shown), however due to changes in protein concentration
throughout encystation I believe that normalization per cell more accurately reflects SL
abundance in each stage. This increase of SM in the cyst form of the parasite is unexpected and
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requires further investigation. Changes in individual lipid species relative to trophozoites are
shown by heat mapping (Fig 2.16).

Figure 2.15: Comparison of total SL abundance during encystation
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Figure 2.16: Heat map illustrating relative changes in neutral sphingolipid species.

2.2.4 Ceramide-sphingomyelin interplay
Although all neutral SLs increase during encystation, they do not increase to the same
extent and therefore the percentage of total SL (Fig. 2.17) described by Cer becomes larger
during encystation (~11% in trophozoites to ~44% by 24 h.p.i.). While the percentage described
by SM is reduced (~87% in trophozoites to ~46% by 24 h.p.i.) indicating hydrolysis of SM likely
as a result of gASMLPD3b1 and/or gASMLPD3b2. During this same period the percentage of
trihexosylceramide and dihexosylceramide are doubled (from less than 1% to 3 and 4%
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respectively). Between 24 h.p.i and water resistant cysts (~48 hours) there is an increase in SM
concentration (Fig. 2.15B), which leads to a compositional shift resulting in SM accounting for
~94% of the total SL in cysts. The differences during encystation can be accounted for at least in
part by an increase in Cer concentration and percentage in encysting media vs. culture media
(Fig. 2.17B) where 11% of SL in culture media is Cer which increases to 20% in encysting
media. However this does not explain the dramatic increase in SM found in the cyst, more so
because SM is lower in encysting media than culture media (65% vs. 77%).

Figure 2.17: Percent composition of sphingolipids by class during differentiation
A. Demonstrates the total SL composition by lipid class in trophozoites, 12 and 24 h.p.i.
and water resistant cysts. A shift from high SM to nearly equivalent Cer/SM occurs by 24 h.p.i.
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then returns to high SM in cysts. B. shows that this change is not due to differences in the SL
composition between culture media and encystations media.

We have been unable to identify any SM synthase gene in the Giardia Genome Database
(www.giardiaDB.org); however that does not preclude the possibility that they are synthesizing
this molecule by some unknown mechanism. Additionally, although the cyst wall is purported to
isolate the cells from the environment, it is possible that they are continuing to uptake SM from
the culture media during cyst wall formation or even after the wall has been produced
completely. Given that transcriptional evidence suggests reduced SMase production in cysts
(Hernandez et al. 2008; Morf et al. 2010), it would not be unreasonable to speculate that this
lipid is no longer being hydrolyzed and as a result, stored by the parasite for future use during
excystation.
2.3

CONCLUSION
SLs are important bioactive lipid-mediators of eukaryotic cells. These molecules are

critical components of the plasma membrane as well as signaling pathways for a diverse range of
functions from differentiation to apoptosis. Bioactive SLs such as Cer and SM have been shown
to mediate these functions based in part upon the combination of acyl chain and sphingoid base.
Here, I report for the first time the sphingolipidome of Giardia lamblia throughout its life cycle.
It was observed that these lipids are differentially taken up from the extracellular sources and
differentially regulated during encystation. There is evidence that longer chain ceramides are
favored during cyst formation and the fact that the intracellular and extracellular SL
compositions are not identical indicates that Giardia remodel these lipids to suit their
requirements.

In accordance with previous reports for glycosphingolipid changes during

encystation (Stefanic et al. 2010), I show that trihexosylceramide levels increase dramatically by
24 h.p.i., contrary to these reports however, I found that the same is true for both mono and
dihexosylceramides.

The interplay between ceramide and SM during cyst formation and
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subsequent storage of SM in the cyst form is a novel finding which suggests that the metabolism
of SM may be important for the production of cysts. This investigation provides support for a
number of future investigations into the mechanism of SL regulation (uptake, remodeling,
hydrolysis) as well as the effects that these molecules have on cyst formation and the outcome of
cyst formation should this regulation be disrupted.
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Chapter 3: Regulation of Sphingomyelin
Sphingomyelin (SM) is the most abundant SL in eukaryotic cells, and Giardia is no
exception to this. However, as shown above, during cyst formation the log difference between
SM and ceramide is reduced such that they are nearly equivalent in abundance. This dramatic
change indicates an important role for the modulation of this SL which is likely achieved through
the action of giardial SMase enzymes. Furthermore, the subsequent abundance of SM in cysts is
a possible indicator of cyst viability and requires further investigation.
SM is a major constituent of membrane microdomains (Bartels et al. 2008; Simons and
Sampaio 2011; Slotte 2013) or lipid rafts. Lipid rafts are discreet aggregations of lipid rich in
SM, cholesterol and PC that have been shown to play important roles in cellular signaling
(Lingwood and Simons 2010; Simons and Gerl 2010). Regulation of SM in these rafts is
achieved through membrane bound hydrolytic enzyme neutral SMase, which cleaves the head
group forming Cer and phosphocholine. In humans there are at least seven SMase enzymes, the
activity of which are pH dependent as well as both cell and tissue specific [reviewed in (Liu et
al. 1997; Goni and Alonso 2002; Zeidan and Hannun 2010)]. Acid SMase is lysosomal and
defects in the synthesis of this enzyme in humans leads to the lysosomal storage disorder
Niemann Pick disease (Vanier 2013). Neutral SMases are a very large family associated with
maintenance of Cer/SM in lipid rafts at the plasma membrane.

The alkaline SMases are

associated with regulation of SM within the nucleus of cells but are better known as digestive
enzymes in the intestine.
As mentioned previously Giardia maintain two copies of acid SMase-like
phosphodiesterase 3b precursors i.e., gASMLPD3b1 and gASMLPD3b2. In humans, SMPDL3b is associated with the protective effect of rituximab in preventing focal segmental
glomerulosclerosis (FSGS) after kidney transplantation (Fornoni et al. 2011).

The authors

hypothesized that this protective effect is achieved by preventing the down regulation of
SMPDL-3b thereby protecting against FSGS by maintaining the integrity of the actin
45

cytoskeleton and podocyte generation. This hypothesis is supported by the finding of that
rituximab treatment of lymphoma cells regulates raft associated ASMase (Bezombes et al. 2004).
Taken together these reports identify a possible association between SMPDL-3b and raft
associated cytoskeletal remodeling, just such remodeling as is required during cyst formation in
Giardia lamblia.
I investigated SM uptake as well as SMase activity during stage differentiation in G.
lamblia. I found that both gASMLPD3b1 and gASMLPD3b2 are functional enzymes which are
differentially expressed throughout encystation. I also noticed that Giardia uptake SM at all
stages during differentiation, including cysts and that viable cysts are more abundant in this SL.
Modulation of SM is mediated at least in part by gASMLPD3b1 which localizes to discreet areas
throughout the cytoplasm of Giardia most likely associated with the TVN and overexpression of
gASMLPD3b1 reduces excystation efficiency in vitro.
3.1

MATERIAL AND METHODS
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Figure 3.1: Flow chart of methods for chapter 3
3.1.1 Deuterated Sphingomyelin and Ceramide Labeling
Approximately, 1x107 trophozoites were harvested as described above and re-suspended
in 1 ml of labeling media (i.e., TYI-S-33 media, pH 7.1 without bovine serum or bile) for 1 h at
37 °C. 100 μl of 100 nmol/µl deuterated sphingomyelin (D31 d18:1/16:0) or deuterated ceramide
(D31 d18:1/16:0) in PBS with 0.1% BSA (fat-free) was added and incubated for an additional
hour at 37 °C. Cells were washed in PBS containing 0.1% BSA and centrifuged, and SLs were
extracted and analyzed as described above for quantitative sphingolipidomics.
3.1.2 Incorporation of fluorescent tagged lipids
To identify uptake of lipids during cyst formation, trophozoites, encysting cells (24 h.p.i.)
and fractionated cysts (1.0M, 1.5M and Pellet) were harvested as described above. Each was
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then incubated for 1h in serum and bile free TYI-SS media followed by addition of Bodipy-SM,
Bodipy-Cer or Bodipy-PC (1uM final concentration) and incubated for an additional 1h at 37 °C.
cells were then washed 3x in PBS, fixed with 4% PFA for 15min at RT and mounted onto
microscope slides in DAKO mounting media. Samples were analyzed in a confocal microscope
(Carl Zeiss Laser Scanning Systems LSM 700), using the Zen 2009 software (Carl Zeiss) for
acquisition and image analysis.
3.1.3 Isolation of cysts by sucrose-density gradient
The step gradient of sucrose (0.5 M, 1.0 M and 1.5 M) was formed in round-bottom glass
tubes (13 x 100 mm). Water-resistant cysts harvested as described above were re-suspended in 1
ml sterile water applied on the layer of the gradient and centrifuged for at 400 × g for 30 min at 4
°C. The cysts formed distinct clusters at the 0.5 M and 1.0 M interface (1.0 M), the 1.0 M and
1.5 M interface (1.5M), and also at the bottom of the tube (Pellet). Cysts were collected from
each layer by carefully pipetting and then washed extensively in cold, distilled H2O prior to
processing for subsequent analyses as described in the text.
3.1.4 Cyst viability
Fluorescein diacetate (FDA) inclusion and propidium iodide (PI) exclusion experiments
were performed to monitor cyst viability. Briefly, a 25 mm stock solution of FDA and PI
(Sigma) was prepared in 100 mm phosphate buffer, pH 6.0, from which a working solution was
made by adding 40 μl of stock to 10 ml of phosphate buffer. Cyst fractions were collected as
described above. Approximately 107 cysts were subjected to FDA and PI staining as described
previously by Gillin colleagues (Mendez et al. 2013). Cysts were washed in PBS, re-suspended
in DAKO mounting media, and mounted on a glass microscope slide. Samples were analyzed on
a confocal microscope (Carl Zeiss Laser Scanning Systems LSM 700), using the Zen 2009
software (Carl Zeiss) for acquisition and image analysis.
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3.1.5 Recombinant gASMLPD3b1 and gASMLPD3b2
Plasmid Construction
The entire open reading frames of gASMLPD3b1 and gASMLPD3b2, ORF_8360 and
ORF_16737

respectively,

were

amplified

by

PCR

using

the

primers

5’-

ATGCGAATCCATGTTCTTGGCCGTGCTGCTCCTCTCT – 3’and 5’ – GCATTGCGGCCG
CCTGCAACTTGGCTAAACATGACTTGTATGACTC – 3’ for gASMLPD3b1 and 5’ –
ATGCG

AATCCATGAAGGCCCTCTTTTACATAGGTTTG

–

3’

and

5’

–

GCATTGCGGCCGCGTTG GAGTTGCTAAGGTTATACGCGTC – 3’ for gASMLPD3b2.
The purified PCR products were digested with EcoR1/Not1 and independently ligated into
EcoR1/Not1 digested pT7CFE1-CHIS expression vector (Thermo Scientific). The new plasmids
pT7CFE8360cHIS and pT7CFE16737cHIS were then transformed into competent DH5α cells
and plated onto LB plates containing 100μg/ml ampicillin. Colonies were screened by PCR and
positive colonies were sequenced at the University of Texas-El Paso (UTEP) DNA core facility.
The ABI Prism BigDye Terminator v3.1 Cycling Sequencing Kit (Applied Biosystems,
Carlsbad, CA) was used to amplify the DNA with fluorescently labeled dideoxynucleotides. The
sequencing reaction was subsequently cleaned using Agencourt Clean SEQ (Beckman Coulter,
Brea, CA).
In-vitro translation
Plasmids were purified with Qiagen midi-prep kit excluding addition of RNaseA to
resuspension buffer (Qiagen). DNA was diluted to 0.5µg/µl and used as template for in vitro
translation using the 1-Step Human High-Yield Mini IVT Kit (Thermo Scientific) according to
manufacturer’s instructions. A positive control expressing green fluorescent protein (GFP) and a
template free negative control were included. Translation efficiency was assessed by western
blot analyses using anti-HIS antibody (Promega). Translated protein was used immediately or
stored at -20 °C for no more than one week.
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3.1.6 Sphingomyelinase Activity
Sphingomyelinase (SMase) activity was assayed with the Amplex Red Sphingomyelinase
assay kit according to manufacturer’s instructions (Invitrogen) using the one-step method to
assay neutral sphingomyelinase activity and the two step method to assay acid sphingomyelinase
activity. For each assay, fluorescence measurements were normalized to protein concentration.
3.1.7 Cleavage of NBD-SM
For initial validation of SMase activity of in vitro translated (IVT) protein, SM hydrolysis
was monitored as described previously (Loidl et al. 2002). Briefly, equivalent concentrations of
protein from gASMLPD3b1 and gASMLPD3b2 as well as negative control IVT reactions were
incubated in neutral (200mM Tris, pH7.4 10mM MgCl), Acid (50mM NaOAc, pH 5.0) or Acid
with Zinc (50mM NaOAc, pH 5.0 10mM ZnCl) buffer with 1uM (final concentration) NBD-SM
for 2 h at 37 C. The reactions were stopped by addition of 600 μl CHCl3:MeOH 2:1, vortexed
briefly, then centrifuged at 5000 xg for 5min. The lower CHCl3 phase was transferred to a fresh
tube, dried under N2 and resuspended in 10uL CHCl3:MeOH 1:1. 5uL of each reaction was
loaded onto HPTLC plates with 5uL Microcaps™ (Drummond Scientific).

HPTLC was

resolved in 65:25:4 CHCL3: MeOH: H2O.
3.1.8 Overexpression of gASMLPD3b1 in Giardia
Plasmid Construction
For overexpression, a small peptide-epitope (AU1)-tagged pNT5 expression plasmid
(obtained from Dr. Chin-Hung Sun, Taiwan) containing gASMLPD3b1 gene under control of the
constitutive alpha2 tubulin promoter was constructed following the method described by Pan et
al. (Pan et al. 2009). The entire open-reading frame of gASMLPD3b1 ORF_8360 was amplified
by PCR using the primers 5‘-GCGCCATGGGGATG TTCTTGGCCGTGCTGCTC-3‘ and 5‘GCGGAATTCTCAGATGTATCGATACGTATCCTG CAACTTGGCTAAACATG -3‘. The
insert was digested with EcoR1/Nco1 and ligated into EcoR1/Nco1-digested dephosphorylated
pNT5 plasmid (Pan et al. 2009). This new plasmid pN8360cAU1 was then transformed into
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competent DH5α cells and plated onto LB plates containing 100μg/ml ampicillin. Colonies were
screened by PCR and positive colonies were sequenced at the University of Texas-El Paso
(UTEP) DNA core facility. The ABI Prism BigDye Terminator v3.1 Cycling Sequencing Kit
(Applied Biosystems, Carlsbad, CA) was used to amplify the DNA with fluorescently labeled
dideoxynucleotides. The sequencing reaction was subsequently cleaned using Agencourt Clean
SEQ (Beckman Coulter, Brea, CA).
Transfection
The parasites were placed in a 4-mm electroporation tube (Fisher Biotech, Waltham,
MA) in a 300-μl suspension of TYI-SS media where 40μg of the pN8360cAU1 plasmid was
added. Trophozoites were then transfected by electroporation on a BioRad Gene Pulser X cell
(BioRad, Hercules, CA) using the following parameters: 322 V, 500 μF, and ∞Ω resistance (4mm cuvette). Cells were allowed to recuperate in media overnight, followed by selection with
150μg/ml G418 (Sigma Aldrich, St. Louis, MO). Stable transfectant trophozoites overexpressing
gASMLPD3b1 (+SMPDL-3b1) were established within two weeks.
3.1.9 Western blot analysis
Parasites were harvested and resuspended in lysis buffer (5mM Tris HCl; Triton X-100;
0.1%; pH 7.4) containing protease inhibitor cocktail and E-64 (1 μM, Sigma). The sample was
freeze thawed at -80 °C followed by sonication. This crude lysate, or IVT protein, was boiled in
sample buffer before being analyzed (100 μg protein/lane and 10μg protein/lane respectively) by
10% SDS-PAGE, and was followed by immunoblotting analysis on the polyvinylidene fluoride
(PVDF) membrane. The membrane was blocked in 1% BSA, incubated with appropriate primary
antibody, anti-AU1 antibody (1:200 monoclonal, Covance) or anti-HIS antibody (1:200
monoclonal, Promega) and incubated overnight at 4 °C. The PVDF membrane was then
incubated with anti-mouse HRP conjugate (1:10,000; KPL, Inc., Washington, DC) for 1h at
room temperature. The enhanced chemi-luminescence (ECL) technique was used for the
detection of protein bands.
51

3.1.10 Staining with anti-AU1 antibody for immunofluorescence
To monitor the cellular localization of SMPDL-3b1, cells (+SMPDL-3b1) were labeled
with mouse ascites anti-AU1 antibody (1:200, Covance). Cells were harvested and fixed to slide
covers using 4% paraformaldehyde (PFA) followed by permeabilization with 0.2% Triton-X100.
Fixed samples were allowed to react with anti-AU1 antibody overnight at 4 °C, followed by
reacting with anti-mouse Alexa Fluor® 568 (Invitrogen). Cells were subsequently incubated with
4', 6-diamidino-2-phenylindole (DAPI; Invitrogen) and mounted with DAKO mounting media
(Agilent Technologies). Samples were analyzed in a confocal microscope (Carl Zeiss Laser
Scanning Systems LSM 700), using the Zen 2009 software (Carl Zeiss) for acquisition and
image analysis.
3.1.11 Staining of Lysosome and Endoplasmic Reticulum
To determine likely cellular localization of ASMLPD-3b1 cells were labelled with ERtracker™ Green or LysoTracker® Green DND-26 (Invitrogen) according to manufacturer’s
instructions and compared staining with anti-AU1 antibody by confocal microscopy. Cells were
allowed to attach to microscope slide covers in TYI-SS media at 37 °C for 15 minutes. The
media was then aspirated and replaced with Hepes buffer (pH7.1) containing 100nM ERtracker™ green or LysoTracker® Green DND 26. These were incubated for an additional 15
minutes at 37 °C, then inverted onto microscope slides and visualized within 10 minutes in a
confocal microscope (Carl Zeiss Laser Scanning Systems LSM 700), using the Zen 2009
software (Carl Zeiss) for acquisition and image analysis.
3.1.12 Detection of secreted protein in spent media
To determine if gASMLPD3b1 is secreted from the cell, western blot was performed with
proteins extracted from the spent media. 25cm2 flasks were of +gASMLPD3b1 trophozoites
were grown to early log phase. 50ml of spent culture media was decanted and centrifuged at
20,000 x g for 30min, transferred to fresh tube and centrifuged at 20,000 x g for an additional 15
min. Cleared media was then dialyzed extensively against 5mM Ammonium Bicarbonate for 24
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h at 4°C followed, frozen and lyophilized. Lyophilized samples were resuspended in 5ml lysis
buffer (100mM Tris-HCL 0.2% triton x-100 pH 7.4), protein was quantified by Bradford assay
(BioRad) and 100μg of protein was used for SDS-PAGE followed by Western Blot as described
above.
3.2

RESULTS

3.2.1 Cysts rich in SM are viable and excyst efficiently
The production and maintenance of viable cysts by Giardia is critical for establishing
infection (giardiasis) in its mammalian host. Earlier reports suggest that gGlcT1 by this parasite
is linked to cyst viability (Mendez et al. 2013). It was also reported by Gillin et al. (1989) that
giardial cysts produced in culture (i.e., in vitro-derived) are of two kinds—oval-shaped classical
cysts with refractive cyst walls (type I) and non-classical/non-oval-shaped (type II) cysts. It is
interesting to note that in vitro-derived cysts are generally less viable than natural cysts and only
type-I cysts are viable and undergo excystation both in vivo and in vitro (Boucher and Gillin
1990). Because our results show that SM concentrations are high in cysts (Fig 2.15 and 2.17), we
asked if the increased levels of SM could be an indicator/determinant of cyst viability. In order
to investigate this, in vitro-derived cysts were subjected to sucrose-density gradient
centrifugation as described in Materials and Methods. Gradient centrifugation yielded three
populations of cysts based on their buoyant densities i.e. cysts found in 1.0 M and 1.5 M
gradients as well as sediment (as a pellet) at the bottom of the tube (Fig. 3.2). To assess viability,
these three populations of cysts were labeled with cell-permeable fluorescein diacetate (FDA)
and the cell-impermeable nucleic acid staining agent, propidium iodide (PI) (Mendez et al.
2013). Although the morphology of cysts in the pellet fraction was consistent with what would
be expected from viable cysts (ovoid, thick cyst walls), we found that the majority (~98%) of
cysts in this fraction are non-viable (Fig. 3.2 A v,vi; B i). While cysts from 1.5 M fraction show
~15% viability, 1.0 M cysts contain the highest percentage of viable (~40%) cysts.
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Because FDA/PI assay is an indirect measure of viability (Smith and Smith 1989), we
carried out in vitro excystation experiments following the protocol described by Gillin and
Boucher (Boucher and Gillin 1990). However, given that the assessing of excyzoites by
microscopy can be erroneous, we placed excysted cells in fresh culture media and monitored the
growth of trophozoites for 72 h. It was observed that the cysts collected from 1.0 M fraction
showed maximum excystation, with nearly every tube containing sufficient excyzoites to show
growth within the allotted time (Fig. 3.2 B ii).
To identify a possible correlation between viability and SL abundance, we performed
quantitative MS analyses. Analyses revealed that although Cer and GSL concentrations within
cysts are higher than trophozoites, the 1.0 M fraction consistently has the highest level of SLs
compared with the other two cyst fractions. Furthermore, the SM level is highest within the 1.0
M fraction (significantly higher than the 1.5 M fraction and trending higher than the pelleted
fraction) indicating a possible link between cyst viability and SM concentration (Fig. 3.2 C).
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Figure 3.2: Viability of cysts separated by density centrifugation.
A. Representative confocal images showing labeling of FDA (green) and PI (red) in
1.0M fraction (i, ii) 1.5M fraction (iii, iv) and pellet (v,vi). B. i. Quantitation of microscopy,
graph represents the percentage of cells out of 100 for each sample incorporating either FDA
(viable), PI (non-viable) or both (non-viable). ii. in vitro excystation of cysts from each fraction.
The graph shows the result of three separate excystation experiments followed by culture for 72
h; growth was assessed by visual inspection of culture tubes. C. Abundance of SLs in cysts
recovered from each of three sucrose fractions
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3.2.2 SM is taken up by trophozoites, encysting cells and cysts.
To verify that Giardia is able to scavenge SM from the media and hydrolyze to form Cer,
we cultured ~1 x 107 cells in the presence of deuterated SM followed by the extraction of SL and
identified by high-resolution mass spectrometry. SIM of the deuterated SM at 734.7694
identified a very intense peak (107), and hydrolyses of that species to ceramide was verified by
SIM of deuterated ceramide at 569.7140, which resulted in a peak of less intensity (105) that did
not appear in control cells. To investigate if SM is synthesized directly from ceramide taken up
by the parasite from the media, we cultured ~1 x 107 trophozoites in the presence of deuterated
ceramide and as expected we identified an intense peak (1.4 x 107) at 569.7140. We were unable
to identify a peak corresponding to deuterated SM at 734.7694, which suggests that SM that is
present in cysts is not synthesized from the ceramide directly. Thus, the large increase in SM in
cysts could be due to the continued influx of SM into the cells during encystation without a
subsequent efflux of this material or hydrolysis to ceramide.
Because SM is more abundant in cysts than trophozoites, I investigated the incorporation
of fluorescent tagged SM in encysting cells as well as cysts. As figure 3.3 shows fluorescent
SM, PC and Cer are readily taken up by trophozoites, encysting cells and cysts. However,
whereas SM and Cer intensely label cysts, PC is much less intense indicating that this lipid is not
incorporated as efficiently into cysts as either Cer or SM. This finding is interesting as it
parallels a previous report that the uptake of fluorescent Cer and SM is sensitive to cytoskeleton
destabilizing inhibitors, whereas the uptake of PC is not. This suggests that cysts maintain active
mechanisms for the transport of SLs into the cell, whereas cytoskeleton independent endocytosis
is dramatically reduced.
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Figure 3.3: Uptake of fluorescent lipids in trophozoites, encysting cells and cysts.
3.2.3 ASMLPD3b1 and ASMLPD3b2 are both active enzymes
The genome sequence of Giardia predicts two SMase genes, gASMLPD3b1 and
gASMLPD3b2. Previously, we have reported that transcription of these enzymes changes during
differentiation, with increased transcription at 6 and 12 h.p.i. (Hernandez et al. 2008).
Proteomics studies have identified peptides aligning with ASMLPD-3b1 but not ASMLPD-3b2
(Jedelsky et al. 2011). Analysis of these proteins with the Sanger institutes database of protein
families Pfam (Punta et al. 2012), indicate that gASMLPD3b2 contains a calcineurin-like
phosphoesterase domain as well as pfamB-682 domain whereas due to 2 point mutations in the
metal binding domain Pfam does not recognize the phosphoesterase domain of gASMLPD3b1.
Similar to both gASMLPD3b2 and human SMPDL-3b, gASMLPD3b1 does contain the pfamB682 domain, however the function of this domain is unclear. Taken together these data are
inconclusive, though both enzymes are transcribed only one was found to be translated by
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proteomics screens, however that enzyme does not possess a clear functional phosphodiesterase
domain.
To resolve these questions and confirm that the two Giardia SMase enzymes are indeed
able to catalyze the hydrolysis of sphingomyelin to ceramide, I performed in-vitro translation of
recombinant gASMLPD3b1 and gASMLPD3b2 with C-terminal His-tags followed by
fluorescence assays under both acidic and neutral conditions.
Both enzymes were readily translated and identified by western blot (Fig. 3.4A), however
as is often the case with lipid metabolic genes, even under these conditions both are insoluble in
the reaction mixture, therefore purification was not possible.

Insolubility was not due to

misfolding because I found that both enzymes are able to hydrolyze SM to Cer (Fig. 3.4C).
Quantitation of this hydrolysis using the Amplex Red (Invitrogen) indirect SMase assay suggests
that, whereas gASMLPD3b2 shows similar activity in both acidic and neutral buffers,
gASMLPD3b1 activity is significantly inhibited in neutral buffer (pH 7.4) yet displays high
activity in acid buffer (pH 5.0). This is unexpected considering the PIs of these enzymes are 5.7
and 6.5 respectively. Of course it is possible that the decrease in activity of gASMLPD3b1 is
due to the effect of magnesium in the neutral assay buffer as exemplified by the strong inhibition
of activity in acid buffer after addition of zinc. Further experiments should be performed to
investigate the effects of other divalent cations in this assay system. Given high activity of
gASMLPD3b1 in acidic conditions, it is likely that this enzyme is not involved in the hydrolysis
of SM at the plasma membrane, and is likely confined either to lysosomal like compartments
(PVs or the TVN) or is secreted from the cell. These are both supported by a recent report
identifying gASMLPD3b1 as an N-glycosylated protein likely secreted or membrane bound
within lysosomes (Ratner et al. 2008).

Although the predicted molecular weight of

gASMLPD3b1 is ~50kD, the enzyme consistently migrates at ~45kD on SDS-PAGE. This
indicates possible cleavage of the enzyme at the amino terminus and likely removal of the
transmembrane domain (~20 amino acids, 4kD) providing evidence that this enzyme could be
secreted to the cell exterior. The promiscuous activity of gASMLPD3b2 is also interesting and
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suggests that in vivo this enzyme could be membrane bound at the plasma membrane. Further
investigation into this is required to identify the cellular context of these sphingomyelinase
enzymes.

Figure 3.4: Expression and activity of recombinant sphingomyelinase
A. Western blot probed with anti-His antibody showing translation of recombinant
enzymes.

B.

Sphingomyelinase activity under various conditions.

Activity presented as

fluorescence (excitation 530/ emission 560) per μg of protein in each reaction. C. HPTLC of
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NBD SM hydrolyzed by control Sphingomyelinase (from B. cereus), gSMDL-3b1 and
gASMLPD3b2 under neutral and acidic conditions.

3.2.4 gASMLPD3b1 localizes to the TVN but not PVs
As stated earlier the ultrastructure of Giardia cells is quite different from higher
eukaryotes. The parasite lacks mitochondria, peroxisomes and lysosomes. The primitive Golgi
is found as a transient structure present only during encystation. In the place of some of these
organelles the parasite has organelles whose function has not been established (mitosome) or
whose function is altered (acidified peripheral vacuoles). The ER of Giardia is part of a
labyrinthine TVN proposed to act as both ER and an endosomal/lysosomal compartment
(Abodeely et al. 2009). Acidified peripheral vacuoles traditionally believed to be lysosomes
may be the sites of clatherin mediated endocytosis (Hernandez et al. 2008; Abodeely et al. 2009)
and either fuse to or are contiguous with this TVN.
Because of the acidic pH optimum for gASMLPD3b1, I hypothesized that this enzyme
would inhabit these acidified vesicles which reside just under the plasma membrane and serve to
break down SM as it was taken up from the extracellular milieu. However, immunofluorescence
with anti-AU1 antibody coupled with both lysosome and ER labeling dyes suggests that this is
not at all the case. In fact, although under the current experimental conditions it is not clear if
gASMLPD3b1 is localized to the TVN or another discreet vesicle, it is clear that it does target to
the perinuclear membrane as well as a tubular network similar to the TVN (Fig 3.5C arrows) and
it does not localize to the PVs (Fig 3.5C arrow heads). Of course LysoTracker® is designed to
label acidified compartments and it would appear that these also form a complex network within
these cells. I hypothesize that this is because the TVN and PV are in fact contiguous, therefore
in areas where these organelles intersect the pH is low enough to label with LysoTracker as well
as provide an environment suitable for SMase activity. It is possible that, precisely because of
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gASMLPD3b1 residence within this network, the enzyme is so dramatically inefficient at higher
pH, indicating a possible mechanism for controlling unwanted SM hydrolysis in the ER.

Figure 3.5: Cellular localization of gASMLPD3b1, ER and acidified vesicles in Giardia
A. Western blot probed with anti-AU1 antibody showing specificity for gASMLPD3b1AU1 B. Identification of gASMLPD3b1-AU1 in spent media C. gASMLPD3b1 localizes to a
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tubular structure as well as the perinuclear membrane similar to the ER marker (arrows).
However it does not localize with the acidified peripheral vacuoles (arrow heads). Bar = 5μm
3.2.5 gASMLPD3b1 is secreted from the cell*
Because gASMLPD3b1 is an N-glycosylated protein and potentially secreted from the
cell, I analyzed spent culture media for the enzyme. Western blots probed with anti-AU1
antibody did reveal the presence of the recombinant enzyme in these samples (Fig. 3.5 B). This
is a novel finding and requires further investigation. Previous reports have identified that
Giardial cells co-cultured with human epithelial cells (caco-2) results in membrane dysfunction
of these cells associated with both secretion of unknown Giardia factors as well as adhesion by
the parasite (Ringqvist et al. 2008; Maia-Brigagao et al. 2012).

Interestingly, exogenous

addition of sphingomyelinase to this same cell line leads to a similar disturbances in cell barrier
function (Bock et al. 2007). Further experiments should pursue this possible link between
Giardia virulence and possible sphingomyelinase disruption of host epithelial barrier function.
3.2.6 gASMLPD3b1 overexpression reduces excystation efficiency
Sphingomyelinase is a key regulator of the composition of plasma membranes and
therefore increased activity of these enzymes could lead to a destabilization of lipid rafts.
Furthermore, the product of sphingomyelinase, Cer, is a potent activator of a wide range of
cellular signaling pathways linked to autophagy, senescence, differentiation and apoptosis
(Obeid and Hannun 1995; Liu et al. 1997; Hannun and Obeid 2008). My mass spectrometry
analyses indicated that SM is abundant in viable cysts and therefore represents a possible target
for prevention of excystation, a critical event in the life cycle of Giardia for maintaining
infectivity.
I asked if the effect of increased SM hydrolysis caused by overexpression of
gASMLPD3b1-AU1 would interfere with growth, encystation or excystation of Giardia. Initial
experiments suggest that cells overexpressing this enzyme grow at the same rate as empty vector
transfected controls (Fig 3.6 A) and encystation does not appear to be hindered (not shown).
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Interestingly in vitro excystation was reduced in cells overexpressing gASMLPD3b1, however
this difference was not significant.

Excystation efficiency was monitored by counting

trophozoites seven days after in vitro excystation as described by Gillen and Boucher (1990). It
is possible that this lag time (between excystation and quantitation) could be resulting in
arbitrarily inflated cell counts for sphingomyelinase overexpressing cells. Alternatively, I have
shown that this enzyme is not located at the plasma membrane rather it is located to organelles
within the cell and due to it this isolation may play a limited role in the maintenance of SM in
cysts.

Additional work to overexpress gASMLPD3b2 will potentially shed light on these

findings and I hypothesize that this enzyme will be localized to the plasma membrane and
exhibit stronger control over SM in cysts.

Figure 3.6: Effects of gASMLPD3b1 overexpression on cell growth and excystation
A. gASMLPD3b1 overexpression does not alter vegetative growth of Giardia
trophozoites. B Excystation efficiency is reduced in cysts overexpressing gASMLPD3b1.
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3.3

CONCLUSION
The transformation from trophozoite to cyst and cyst to trophozoite constitutes the life

cycle of Giardia and is critical for infecting it mammalian host. I found that the efficiency of
excystation correlates with SM content of the Giardia cyst, i.e. those cysts that are highest in SM
content are more viable and excyst efficiently compared to low SM containing cysts (Fig. 3.1).
This is a novel finding, and future studies should be conducted to confirm this and possibly
identify the mechanism by which SM could maintain the cyst viability. During excystation cysts
pass through acidic pH of the stomach, release two trophozoites, and ultimately colonize in the
small intestine (pH ~7.8), where newly emerged trophozoites are exposed to high levels of
digestive enzymes, dietary lipids and bile salts
The modulation of SM is carried out by one or both of the Giardia SMase enzymes
which are differentially expressed during encystation and excystation. I found that both of these
enzymes are able to efficiently hydrolyze SM to Cer, furthermore, gASMLPD3b1 localizes to
the TVN which houses both lysosomal and ER functions in this parasite. I hypothesize that
gASMLPD3b1 is secreted from the cell and may potentially be involved in dysregulation of host
epithelial barrier function.

Overexpression of this enzyme reduces excystation efficiency

supporting the role of SM in maintaining cyst viability. However, given the cellular isolation of
gASMLPD3b1 from endocytosed SM, this reduction was not enough to prevent excystation
altogether.

Future studies will include the overexpression of

gASMLPD3b2 followed by

examining its role in modulating and maintaining the level of SM in the plasma membrane
beneath the cyst wall, which could provide a new mechanism of excystation.
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Chapter 4 Discussion
G. lamblia is an evolutionarily conserved organism that likely diverged from higher
eukaryotes prior to the mitochondrial fusion event (Hilario and Gogarten 1998). As a result of
this conservation or as a result of parasitism (Stechmann and Cavalier-Smith 2002), Giardia are
highly streamlined in a number of biological processes including glucose metabolism,
maintenance of genetic material, protein synthesis and lipid neogenesis (Morrison et al. 2007).
Absent a great deal of the complexity found in more derived eukaryotes, they represent an ideal
model for the study of these pathways. Not only is Giardia an excellent model for the academic
study of basic biological processes, it is the leading cause of non-bacteria associated diarrhea
worldwide. Although only sixty percent of cases are symptomatic, this can be a devastating
disease whose acute symptoms of diarrhea and malabsorption can lead to chronic symptoms
ranging from failure to thrive, stunting, chronic fatigue, cognitive disorders, and irritable bowel
syndrome (Ankarklev et al. 2010; Halliez and Buret 2013). The absence of many biological
processes found in higher eukaryotes presents a unique opportunity to devise strategies to fight
this disease, as those processes which are retained by the organism are likely to be essential for
the maintenance of its lifecycle. Previously it was shown that Giardia require SLs for growth
and encystation. In my dissertation I have elucidated the sphingolipidome of Giardia for the first
time. In accordance with the nature of Giardia metabolism, this sphingolipidome is simple (as
compared with higher eukaryotes) and represents the minimum requirements for SL metabolism
during growth as well as differentiation of the eukaryote cell. Parasitism has alleviated the need
for de novo synthesis of many of these lipid molecules, yet the organism has retained machinery
for the manipulation of these molecules indicating that they are essential and modulated actively
during encystation.
I have analyzed this modulation to identify specific SL changes during cyst formation.
The Giardia genome maintains SL metabolism, mediated by the five SL genes i.e. gSPT1,
gSPT2, gASMLPD3b1, gASMLPD3b2 and gGlcT1 and the transcription of these genes is
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differentially regulated during encystation (Hernandez et al 2008). Previous studies from this
and other laboratories have shown that gGlcT1 activity is essential for encystation by Giardia
(Hernandez et al. 2008; Sonda et al. 2008; Stefanic et al. 2010; Mendez et al. 2013).
Additionally, the inhibition of SPT by L-cycloserine, interrupted ceramide uptake and targeting
in trophozoite cells (Hernandez et al. 2008). Given these data, I investigated the changes in SLs
during encystation by analyzing the metabolites themselves, rather than the enzymes responsible
for their metabolism. I chose this approach in order to cast a broader net that would allow me to
identify processes not predicted by the Giardia genome as well as to decipher the alterations in
SLs that could be correlated directly with changes to enzyme production. To initiate this study, I
first standardized a method for the extraction and enrichment of SL species from Giardia
trophozoites, encysting cells and cysts. I found that the complex nature of Giardia cell extracts,
coupled with the low abundance of many SL species required extensive separation of these
extracts prior to analyses. I analyzed SLs by direct infusion into an ion trap mass spectrometer
(LTQ, Thermo) and identified species by total ion mapping and fragmentation analyses. I found
that Giardia have both neutral and acidic glycosphingolipids, including the neutral mono-, di-,
and tri-hexosylceramides as well as hexosamine containing tri-and tetra-hexosylceramides; and
the acidic GM1, GM3 and GD3. I also found both Cer and SM, with SM being the most
abundant SL. Analyses of culture media sources of SL (bovine serum and bovine bile) showed a
very similar profile and I postulated that much of the lipid in giardial cells was taken up from the
culture media. I did not identify any phosphorylated Cer, nor did I identify inositol containing
ceramides.

Furthermore, I was unable to confirm the presence of the sphingoid bases,

sphingosine or sphinganine. This was primarily due to the lack of a distinct fragmentation
profile (both lose H2O, followed by CH2O, fragments that are commonly lost by interfering
compounds) that could be used to isolate these species from the high noise in the low molecular
weight range of the mass spectrometer (m/z 50-350).
This method proved to be quantitative over a narrow linear range and was therefore
inappropriate for the quantitation of Giardia SLs. To overcome this I standardized an additional
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method employing nano-capillary ultra-high pressure liquid chromatography (nano-uHPLC)
separation coupled to high resolution mass spectrometry on a bench top orbitrap mass
spectrometer (QExactive, Thermo). The LC separation resolved SM, Cer, mono-, di- and trihexosylceramides by their fatty acid chains. However once again sphingoid bases did not
resolve with this column and therefore they were excluded from the study. Further I was unable
to identify the hexosamine containing species using this instrument I believe this is due to a
reduction in the extraction of SLs due to a more direct extraction method motivated by the need
for quantitation that was not confounded by loss of sample due to processing.
I found that the abundance of Cer and neutral glycosphingolipids increase ~10 fold
during encystation, then decrease again in cysts. I also found that SM increases during
encystation and remains elevated in cysts with 3 fold increase over trophozoites. Analyses of the
species percent composition of culture media and encystation media showed similar profiles to
one another, yet both differed from Giardia in all life cycle stages, indicating either preferential
uptake or the modulation of fatty acid/headgroup by the cell. Interestingly the trend appears to
be toward an increase in chain length in the cells as compared with media.
The increase in SM in cysts could potentially indicate a requirement for maintaining cell
viability. To assess this, I first separated cysts by density centrifugation, followed by mass
spectrometry to identify high SM containing populations and then viability assay using both vital
dye incorporation and excystation in vitro. I found that there is a correlation between SM
concentration and cyst viability using both viability measurement methods. I speculate that high
SM allows for modulation of the plasma membrane required for survival outside of the host.
Further studies isolating cyst wall and membrane could answer this question and potentially open
a wide range of possible targets for the prevention of excystation.
In my dissertation I sought to investigate the SL metabolic enzyme responsible for the
regulation of SM. As mentioned above the Giardia genome encodes for two acid SMase
phosphodiesterase-like 3b precursor enzymes (gASMLPD3b1 and gASMLPD3b2). However
given the sequence divergence from characteristic acid and neutral SMase enzymes, including
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the lack of SL-binding domain, it was unclear if these enzymes would hydrolyze SM. SL
metabolic enzymes are often hydrophobic proteins with extensive post translational
modifications, making bacterial recombinant production inappropriate for the synthesis of these
enzymes. To circumvent this I used a human coupled in vitro translation kit (1 step Human
Coupled IVT, Thermo) to synthesize gASMLPD3b1 and gASMLPD3b2. I found that both of
these enzymes are functional. gASMLPD3b1 has an acid pH optimum and is inhibited by Zn
and possibly Mg. gASMLPD3b2 is active at both acid and neutral pH, with slightly higher
activity at acid pH, gASMLPD3b2 is also inhibited by Zn.
Within the cell, SM is likely hydrolyzed to Cer, which is then used as a substrate for the
formation of glycosphingolipids beginning with glucosylceramide. Previous reports employing
mass spectrometry of proteins have shown that of the two enzymes, gASMLPD3b1 is translated
in the cell (Jedelsky et al. 2011).

Additionally, gASMLPD3b1 was identified as an N-

glycosylated protein potentially lysosomal or secreted from the cell (Ratner et al. 2008). To
investigate the enzyme more thoroughly I overexpressed an epitope tagged recombinant under
the control of the constitutive alpha-2 tubulin promoter gASMLPD3b1-AU1 in Giardia cells. I
found that the enzyme inhabits the TVN which has been reported to function as both ER and
endosome/lysosome. Given that GlcT1 is likely also an ER resident protein, this fits with the
hypothesis that SM is hydrolyzed to Cer which is subsequently glycosylated, all within the ER.
In mammalian systems, Cer is trafficked by the Cer Transfer protein (CERT) from the Golgi to
the ER, however Giardia lacks both Golgi and CERT, therefore it is parsimonious that Cer
generation would take place at the site of glucosylceramide generation.
Surprisingly I found gASMLPD3b1 in spent media indicating that this enzyme could be
secreted to the environment. Once validated, this could change the paradigm for the causes of
membrane dysfunction in epithelial cells co-cultured with Giardia trophozoites.

Secreted

gASMLPD3b1 could potentially decrease membrane barrier function as has been shown with
exogenous SMase addition to cultured epithelial cells (Bock et al. 2007). However it remains to
be seen if gASMLPD3b1 is active within the pH range found in the intestine.
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Overexpression of gASMLPD3b1 also lead to decreased excystation efficiency, however
excystation was not blocked altogether. Taken together these results suggest that gASMLPD3b1
resides in the TVN where it hydrolyzes SM to Cer for the generation of glucosylceramide.
Regulation of this is potentially mediated by the pH of the environment as high pH reduces the
activity of this enzyme. Additionally, gASMLPD3b1 is likely processed by cleavage of the
transmembrane domain and may be secreted from the cell. Overexpression of this enzyme leads
to a reduction in excystation efficiency; however this excess activity is attenuated due to pH
requirements of the enzyme. I hypothesize that maintenance of SM at the plasma membrane is
carried out by gASMLPD3b2, which has a broader range of activity. Future studies will confirm
this by identifying the cellular localization of this enzyme as well as the effect of overexpression
on excystation efficiency.
4.1

PROPOSED MODEL
Based on the current results as well as previous reports (Hernandez et al. 2007; Abodeely

et al. 2009; Castillo-Romero et al. 2010) a comprehensive model for SL metabolism during
encystation has been proposed (Fig 4.1). The model reveals that SLs are taken up from the
environment by both clathrin-dependent and -independent endocytic pathways. Cer, either in the
extracellular space or produced by activity of gASMLPD3b2, is trafficked to the TVN where it is
the substrate for formation of glucosylceramide mediated by gGlcT1. SM is also transported to
the TVN where it is hydrolyzed by gASMLPD3b1 to Cer which can then be converted to
glucosylceramide. During encystation increased expression of gASMLPD3b1, gASMLPD3b2
and gGlcT1 lead to an increase in the formation of glucosylceramide and this well regulated
increase is required for proper formation of ESVs which carry cyst wall material to be deposited
on the exterior of the plasma membrane (Mendez, 2013). Di and trihexosylceramide levels also
increase and are likely located at the plasma membrane but may potentially aid in the formation
of ESVs similar to glucosylceramide. A simultaneous rise in the level of SM and Cer within the
cell is likely due to increased uptake and also a result of SM hydrolysis mediated by
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gASMLPD3b2 at the plasma membrane stimulating the cytoskeleton-dependent endocytosis. As
more SM is brought in, membrane integrity is restored and SM-rich membrane is abundant with
detergent resistant domains to support survival of cysts at lower temperature.

Figure 4.1: Proposed model of Giardia SL metabolism during encystation
Proposed model which shows sphingolipid uptake and metabolism in trophozoites,
encysting cells and cysts.

4.2

CONCLUSION AND FUTURE DIRECTION
The sphingolipidome of G. lamblia is minimal and composed primarily of lipids which

have been scavenged from the environment. Regulation of the incorporation of these lipids
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coupled with modulation of their fatty acid and polar head group, allow Giardia to fulfill its
requirements for these bioactive molecules. I have shown a clear link between the increase in
SLs and cyst formation as well as a correlation between SM content and excystation. This is the
first time that excystation has been linked with SL and indicates that SLs are critical for all
stages of the parasites life cycle. Furthermore I have shown that Giardia actively modulate SM
levels with both increased uptake and enzymatic hydrolysis. These data suggest that Giardia is
strongly dependent upon the diet of the host and this could potentially serve as an avenue of
investigation for treating the disease. Although it is unlikely that SM could be removed from all
diets, especially in infants as it is a major component of human breast milk, the enzymes
involved in this pathway are ideal candidates for chemical inhibition. The methods developed in
my dissertation open the door for future studies of the lipidome as well as excystation efficiency
of Giardia which, when coupled with genetic modification of SL genes, will provide valuable
insight into potential treatments of this neglected parasite.
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